Verdict
🟠 Highly suspicious. The investigation identifies systematic arithmetic inconsistencies in Table 3 that are inconsistent with the authors' demonstrated arithmetic capability in Table 2, raising substantial concern that statistical results may have been copied or fabricated.
Key findings
- Systematic N discrepancies in Table 3. Sums of study-level sample sizes from Table 1 do not match the totals reported in Table 3 for nearly every clinicopathological subgroup.
- Magnitude of discrepancies ranges from +10 to +47 patients, with Gender showing the largest absolute mismatch (reported 1650; recomputed 1603; Δ = +47).
- Selective inconsistency pattern. Table 2 subgroup arithmetic is exact (e.g., CRC: 105 + 180 + 85 + 164 = 534), demonstrating the authors are capable of correct summation; the failure is therefore not innocent error.
- Unexplained high heterogeneity. I² = 86.2% in the Degree of differentiation analysis is reported without discussion, sensitivity analysis, or subgroup exploration, undermining the validity of the pooled estimate.
- Likely reuse of statistical output. The pattern (precise OR/CI values alongside fabricated N totals) is consistent with the authors having copy-pasted meta-analytic output from a different biomarker review and failing to update the sample-size column.
- DOI: 10.3389/fonc.2022.969632
- Location of primary anomaly: Table 3, Page 07 (Meta-analysis of MSI2 and clinicopathological features in cancer patients)
- Recomputed vs. reported totals (from Table 1 study-level N):
- Age (young vs. old), 12 studies (16, 19, 21, 22, 24, 25, 27, 28, 30, 32, 33, 34): 105 + 75 + 180 + 126 + 82 + 162 + 62 + 164 + 67 + 181 + 149 + 51 = 1404; reported 1414 (Δ = +10).
- Gender (male vs. female), 11 studies: summed = 1603; reported 1650 (Δ = +47).
- Liver metastasis, 3 studies (23, 28, 34): 91 + 164 + 51 = 306; reported 338 (Δ = +32).
- Tumor size, 9 studies: summed = 1002; reported 1012 (Δ = +10).
- Degree of invasion, Lymph node metastasis, Degree of differentiation: also failed independent verification.
- Counter-evidence (Table 2, Page 05): Subgroup sums reconcile precisely, e.g., CRC 105 + 180 + 85 + 164 = 534.
- Secondary anomaly: I² = 86.2% in Degree of differentiation (Table 3) is reported without methodological discussion or sensitivity analysis; pooled result presented as a definitive null (P=0.418).
- All recomputations are derived solely from the published Table 1 study-level N values; the underlying extracted data themselves cannot be verified without the authors' raw extraction sheets and Stata/R logs.
- Discrepancies could theoretically reflect inclusion of patients from overlapping cohorts within a single subgroup; however, this would not explain the precise arithmetic in Table 2 nor the selective failure restricted to Table 3.
- Recommended follow-up: request original extraction tables and complete statistical output logs from the corresponding author; consider formal notification to the journal editorial office and the authors' institutional research integrity committee (affiliation reported: Nanjing Medical University Affiliated Taizhou People's Hospital).